Log in | Register

Early change in blood glucose concentration is an indicator of mortality in critically ill children

Prabhakar P. Nayak| Paul Davies| Parth Narendran| Simon Laker| Fang Gao| Stephen C. L. Gough| John Stickley| Kevin P. Morris
Pediatric Original
Volume 39, Issue 1 / January , 2013

Pages 123 - 128

Abstract

Objective

Hyperglycaemia is associated with increased mortality in critically ill patients. A number of studies have highlighted an association between increased variability of blood glucose (BG) concentration and mortality, supporting a survival disadvantage if BG homeostasis is lost. By exploring the longitudinal BG profile of individual children over time, this study investigates the importance of intact homeostasis early after admission to the paediatric intensive care unit (PICU).

Design, setting, and patients

Retrospective single-centre observational study in a large multi-specialty PICU in the UK. Children admitted between August 2003 and February 2006 were included unless they met exclusion criteria. Data were merged from the PICU clinical database and blood gas analyser database by means of a unique PICU identifier. BG was measured frequently on a blood gas analyser (Bayer Rapidlink). Primary outcome was 100-day mortality. BG parameters were investigated for possible associations with mortality.

Measurements and main results

A total of 1,763 patients were included (median age 1.1 years; IQR 0.1–5.8). Although admission BG was not associated with mortality, a survival advantage was found in children who showed a reduction in BG on day 1 relative to the admission BG value (p < 0.001). This remained statistically significant (p = 0.007) after adjusting for severity of illness.

Conclusions

This study supports an association between early BG profile and mortality in children admitted to PICU, with increased survival in those who demonstrate a fall in BG on day 1 relative to PICU admission. These findings are consistent with a survival advantage of intact BG homeostasis.

Keywords

References

  1. Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic review. Lancet 355:773–778
    • View reference on PubMed
    • View reference on publisher's website
  2. Prieser JC, Devos P, Van den Berghe G (2002) Tight control of glycaemia in critically ill patients. Curr Opin Nutr Metab Care 5:533–537
    • View reference on publisher's website
  3. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE (2002) Hyperglycaemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978–982
    • View reference on PubMed
    • View reference on publisher's website
  4. Hoxworth JM, Xu K, Zhou Y, Lust WD, LaManna JC (1999) Cerebral metabolic profile, selective neuron loss and survival of acute and chronic hyperglycaemic rats following cardiac arrest and resuscitation. Brain Res 821:467–479
    • View reference on PubMed
    • View reference on publisher's website
  5. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367
    • View reference on PubMed
    • View reference on publisher's website
  6. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297
  7. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V (2004) Association of timing, duration and intensity of hyperglycaemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 5:329–336
    • View reference on PubMed
    • View reference on publisher's website
  8. Faustino EV, Apkon M (2005) Persistent hyperglycaemia in critically ill children. J Pediatrics 146:30–34
    • View reference on publisher's website
  9. Yates AR, Dyke PC 2nd, Taeed R (2006) Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med 7:351–355
    • View reference on PubMed
    • View reference on publisher's website
  10. Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM (2006) Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 118:173–179
    • View reference on PubMed
    • View reference on publisher's website
  11. Yung M, Wilkins B, Norton L, Slater A; Paediatric Study Group; Australian and New Zealand Intensive Care Society (2008) Glucose control, organ failure, and mortality in pediatric intensive care. Pediatr Crit Care Med 9:147–152
  12. Hirshberg E, Larsen G, Van Duker H (2008) Alterations in glucose homeostasis in the pediatric intensive care unit: hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med 9:361–366
    • View reference on PubMed
    • View reference on publisher's website
  13. Klein GW, Hojsak JM, Schmeidler J, Rapaport R (2008) Hyperglycaemia and outcome in the pediatric intensive care unit. J Pediatr 153:379–384
    • View reference on PubMed
    • View reference on publisher's website
  14. Rake AJ, Srinivasan V, Nadkarni V, Kaptan R, Newth CJ (2010) Glucose variability and survival in critically ill children: allostasis or harm? Pediatr Crit Care Med 11:707–712
    • View reference on PubMed
    • View reference on publisher's website
  15. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G (2009) Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 373:547–556
    • View reference on PubMed
    • View reference on publisher's website
  16. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, van Weissenbruch M, Midgley P, Thompson M, Thio M, Cornette L, Ossuetta I, Iglesias I, Theyskens C, de Jong M, Ahluwalia JS, de Zegher F, Dunger DB (2008) Early insulin therapy in very-low-birthweight infants. N Engl J Med 359:1873–1884
    • View reference on PubMed
    • View reference on publisher's website
  17. Mackenzie IMJ, Whitehouse T, Nightingale PG (2011) The metrics of glycaemic control in critical care. Intensive Care Med 37:435–443
  18. Slater A, Shann F, Pearson G (2003) Paediatric Index of Mortality (PIM) Study Group. PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 29:278–285
    • View reference on PubMed
  19. Pollack MM, Patel KM, Ruttimann UE (1997) The Pediatric Risk of Mortality III–Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr 131:575–581
    • View reference on PubMed
    • View reference on publisher's website
  20. Nayak PP, Morris K, Lang H, Laker S, Stickley J, Davies P, Barrett T, Gao F, Gough S, Narendran P (2009) Lack of agreement between arterial and central venous blood glucose measurement in critically ill children. Intensive Care Med 35:762–763
  21. Macrae D, Pappachan J, Grieve R, Parslow R, Nadel S, Schindler M, Baines P, Fortune PM, Slavik Z, Goldman A, Truesdale A, Betts H, Allen E, Snowdon C, Percy D, Broadhead M, Quick T, Peters M, Morris K, Tasker R, Elbourne D (2010) Control of hyperglycaemia in paediatric intensive care (CHiP): study protocol. BMC Pediatr 10:5
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement